Detalles de la búsqueda
1.
Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review.
Ann Surg Oncol
; 31(1): 433-451, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777688
2.
Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement.
Dis Esophagus
; 34(12)2021 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100554
3.
ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer.
Ann Surg Oncol
; 31(1): 452-453, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37907700
4.
Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Ann Surg Oncol
; 22 Suppl 3: S1301-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314875
5.
Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer.
Ann Surg Oncol
; 22(2): 552-6, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25155395
6.
Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a case of pembrolizumab associated catastrophic antiphospholipid syndrome?
SAGE Open Med Case Rep
; 8: 2050313X20972225, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33224503
7.
Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus.
United European Gastroenterol J
; 7(7): 889-896, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31428413
Resultados
1 -
7
de 7
1
Próxima >
>>